Verdezyne Wins $1.7M STTR Grant | GenomeWeb

NEW YORK (GenomeWeb News) – Verdezyne has received a $1.7 million grant from the National Institute of Allergy and Infectious Diseases that it will use to develop gene libraries for synthetic biology applications in its fermentation development program, the company said today.

The company, which formerly went by the name Coda Genomics, will use the Small Business Technology Transfer grant to fund development of bioinformatics applications for use in its mutant library and synthetic biology programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.